Autoantibodies in Alzheimer's disease: Potential biomarkers, pathogenic roles, and therapeutic implications

Research output: Contribution to journalReview articlepeer-review

34 Scopus citations

Abstract

Alzheimer's disease (AD) is a prevalent and debilitating neurodegenerative disorder in the elderly. The etiology of AD has not been fully defined and currently there is no cure for this devastating disease. Compelling evidence suggests that the immune system plays a critical role in the pathophysiology of AD. Autoantibodies against a variety of molecules have been associated with AD. The roles of these autoantibodies in AD, however, are not well understood. This review attempts to summarize recent findings on these autoantibodies and explore their potential as diagnostic/ prognostic biomarkers for AD, their roles in the pathogenesis of AD, and their implications in the development of effective immunotherapies for AD.

Original languageEnglish (US)
Pages (from-to)361-372
Number of pages12
JournalJournal of Biomedical Research
Volume30
Issue number5
DOIs
StatePublished - 2016

Keywords

  • Alzheimer's disease
  • Autoantibody
  • Autoimmune
  • Biomarker
  • Immunotherapy
  • Pathogenesis

Fingerprint Dive into the research topics of 'Autoantibodies in Alzheimer's disease: Potential biomarkers, pathogenic roles, and therapeutic implications'. Together they form a unique fingerprint.

Cite this